Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

TRIKAFTA (COPACKAGED)

ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

Standard Dose
50MG,37.5MG,25MG; 75MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary

Approval overview TRIKAFTA (COPACKAGED) is listed in Drugs@FDA under application 212273 (NDA).

Review priority: PRIORITY Marketing status: Prescription Active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR Form and strength TABLET;ORAL - 50MG,37.5MG,25MG; 75MG Sponsor VERTEX PHARMS INC Submission history Latest submission status date: 2026-03-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIKAFTA (COPACKAGED) is listed in Drugs@FDA under application 212273 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR Form and strength TABLET;ORAL - 50MG,37.5MG,25MG; 75MG Sponsor VERTEX PHARMS INC Submission history Latest submission status date: 2026-03-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.